SI-BONE, Inc.
SIBN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.56 | 0.50 | -1.62 | -0.93 |
| FCF Yield | -3.94% | -3.29% | -11.00% | -6.24% |
| EV / EBITDA | -25.28 | -23.58 | -8.80 | -13.99 |
| Quality | ||||
| ROIC | -17.14% | -22.52% | -44.43% | -31.15% |
| Gross Margin | 79.03% | 78.78% | 85.24% | 88.43% |
| Cash Conversion Ratio | 0.40 | 0.43 | 0.68 | 0.70 |
| Growth | ||||
| Revenue 3-Year CAGR | 16.25% | 15.49% | 13.18% | 10.23% |
| Free Cash Flow Growth | 13.54% | 48.18% | -11.41% | -38.22% |
| Safety | ||||
| Net Debt / EBITDA | -0.11 | -0.17 | -0.34 | 0.45 |
| Interest Coverage | -10.25 | -13.56 | -21.15 | -9.63 |
| Efficiency | ||||
| Inventory Turnover | 1.29 | 1.46 | 0.91 | 0.91 |
| Cash Conversion Cycle | 274.28 | 251.69 | 326.64 | 348.19 |